NCT03295240 2025-05-13
The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Completed
Clinical Trials
3 trialsNCT02484053 2018-07-11
Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders
Baylor College of Medicine
Phase EARLY_PHASE1 Completed
NCT00734773 2012-05-18
Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL
Northwestern University
Phase EARLY_PHASE1 Withdrawn